212 related articles for article (PubMed ID: 38512820)
1. Mutations in human prion-like domains: pathogenic but not always amyloidogenic.
Bartolomé-Nafría A; García-Pardo J; Ventura S
Prion; 2024 Dec; 18(1):28-39. PubMed ID: 38512820
[TBL] [Abstract][Full Text] [Related]
2. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS.
Kim HJ; Kim NC; Wang YD; Scarborough EA; Moore J; Diaz Z; MacLea KS; Freibaum B; Li S; Molliex A; Kanagaraj AP; Carter R; Boylan KB; Wojtas AM; Rademakers R; Pinkus JL; Greenberg SA; Trojanowski JQ; Traynor BJ; Smith BN; Topp S; Gkazi AS; Miller J; Shaw CE; Kottlors M; Kirschner J; Pestronk A; Li YR; Ford AF; Gitler AD; Benatar M; King OD; Kimonis VE; Ross ED; Weihl CC; Shorter J; Taylor JP
Nature; 2013 Mar; 495(7442):467-73. PubMed ID: 23455423
[TBL] [Abstract][Full Text] [Related]
3. RNA-binding proteins with prion-like domains in health and disease.
Harrison AF; Shorter J
Biochem J; 2017 Apr; 474(8):1417-1438. PubMed ID: 28389532
[TBL] [Abstract][Full Text] [Related]
4. Cryo-EM structures of functional and pathological amyloid ribonucleoprotein assemblies.
Garcia-Pardo J; Ventura S
Trends Biochem Sci; 2024 Feb; 49(2):119-133. PubMed ID: 37926650
[TBL] [Abstract][Full Text] [Related]
5. Genetic and Pathological Assessment of hnRNPA1, hnRNPA2/B1, and hnRNPA3 in Familial and Sporadic Amyotrophic Lateral Sclerosis.
Fifita JA; Zhang KY; Galper J; Williams KL; McCann EP; Hogan AL; Saunders N; Bauer D; Tarr IS; Pamphlett R; Nicholson GA; Rowe D; Yang S; Blair IP
Neurodegener Dis; 2017; 17(6):304-312. PubMed ID: 29131108
[TBL] [Abstract][Full Text] [Related]
6. The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis.
Bampton A; Gittings LM; Fratta P; Lashley T; Gatt A
Acta Neuropathol; 2020 Nov; 140(5):599-623. PubMed ID: 32748079
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic View of hnRNPA2 Low-Complexity Domain Structure, Interactions, and Phase Separation Altered by Mutation and Arginine Methylation.
Ryan VH; Dignon GL; Zerze GH; Chabata CV; Silva R; Conicella AE; Amaya J; Burke KA; Mittal J; Fawzi NL
Mol Cell; 2018 Feb; 69(3):465-479.e7. PubMed ID: 29358076
[TBL] [Abstract][Full Text] [Related]
8. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics.
Mackenzie IR; Nicholson AM; Sarkar M; Messing J; Purice MD; Pottier C; Annu K; Baker M; Perkerson RB; Kurti A; Matchett BJ; Mittag T; Temirov J; Hsiung GR; Krieger C; Murray ME; Kato M; Fryer JD; Petrucelli L; Zinman L; Weintraub S; Mesulam M; Keith J; Zivkovic SA; Hirsch-Reinshagen V; Roos RP; Züchner S; Graff-Radford NR; Petersen RC; Caselli RJ; Wszolek ZK; Finger E; Lippa C; Lacomis D; Stewart H; Dickson DW; Kim HJ; Rogaeva E; Bigio E; Boylan KB; Taylor JP; Rademakers R
Neuron; 2017 Aug; 95(4):808-816.e9. PubMed ID: 28817800
[TBL] [Abstract][Full Text] [Related]
9. The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disorders.
Gascon E; Gao FB
J Neurogenet; 2014; 28(1-2):30-40. PubMed ID: 24506814
[TBL] [Abstract][Full Text] [Related]
10. No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy.
Seelen M; Visser AE; Overste DJ; Kim HJ; Palud A; Wong TH; van Swieten JC; Scheltens P; Voermans NC; Baas F; de Jong JM; van der Kooi AJ; de Visser M; Veldink JH; Taylor JP; Van Es MA; van den Berg LH
Neurobiol Aging; 2014 Aug; 35(8):1956.e9-1956.e11. PubMed ID: 24612671
[TBL] [Abstract][Full Text] [Related]
11. De novo design of RNA-binding proteins with a prion-like domain related to ALS/FTD proteinopathies.
Mitsuhashi K; Ito D; Mashima K; Oyama M; Takahashi S; Suzuki N
Sci Rep; 2017 Dec; 7(1):16871. PubMed ID: 29203801
[TBL] [Abstract][Full Text] [Related]
12. Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis.
Root J; Merino P; Nuckols A; Johnson M; Kukar T
Neurobiol Dis; 2021 Jul; 154():105360. PubMed ID: 33812000
[TBL] [Abstract][Full Text] [Related]
13. Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis.
Calini D; Corrado L; Del Bo R; Gagliardi S; Pensato V; Verde F; Corti S; Mazzini L; Milani P; Castellotti B; Bertolin C; Sorarù G; Cereda C; Comi GP; D'Alfonso S; Gellera C; Ticozzi N; Landers JE; Ratti A; Silani V;
Neurobiol Aging; 2013 Nov; 34(11):2695.e11-2. PubMed ID: 23827524
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of FUS-associated ALS and FTD: insights from rodent models.
Nolan M; Talbot K; Ansorge O
Acta Neuropathol Commun; 2016 Sep; 4(1):99. PubMed ID: 27600654
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: from structural insights to post-transcriptional regulatory roles.
Bekenstein U; Soreq H
Mol Cell Neurosci; 2013 Sep; 56():436-46. PubMed ID: 23247072
[TBL] [Abstract][Full Text] [Related]
16. ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1.
Gilpin KM; Chang L; Monteiro MJ
Hum Mol Genet; 2015 May; 24(9):2565-77. PubMed ID: 25616961
[TBL] [Abstract][Full Text] [Related]
17. Linking hnRNP Function to ALS and FTD Pathology.
Purice MD; Taylor JP
Front Neurosci; 2018; 12():326. PubMed ID: 29867335
[TBL] [Abstract][Full Text] [Related]
18. From Prions to Stress Granules: Defining the Compositional Features of Prion-Like Domains That Promote Different Types of Assemblies.
Fomicheva A; Ross ED
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513942
[TBL] [Abstract][Full Text] [Related]
19. Perfecting prediction of mutational impact on the aggregation propensity of the ALS-associated hnRNPA2 prion-like protein.
Batlle C; Fernández MR; Iglesias V; Ventura S
FEBS Lett; 2017 Jul; 591(13):1966-1971. PubMed ID: 28542905
[TBL] [Abstract][Full Text] [Related]
20. Cryo-EM structures of the D290V mutant of the hnRNPA2 low-complexity domain suggests how D290V affects phase separation and aggregation.
Lu J; Ge P; Sawaya MR; Hughes MP; Boyer DR; Cao Q; Abskharon R; Cascio D; Tayeb-Fligelman E; Eisenberg DS
J Biol Chem; 2024 Feb; 300(2):105531. PubMed ID: 38072051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
